NASDAQ: ESLA
Estrella Immunopharma Inc Stock Ownership - Who owns Estrella Immunopharma?

Insider buying vs selling

Have Estrella Immunopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cheng LiuCEO2026-08-25100,000$0.82
$81.50kBuy
Jiandong XuCFO2026-08-18100,000$0.82
$81.50kBuy

1 of 1

ESLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ESLA insiders and whales buy or sell their stock.

ESLA Shareholders

What type of owners hold Estrella Immunopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eureka Therapeutics Inc58.11%25,277,831$20.78MInsider
Jianwei Li5.52%2,399,490$1.97MInsider
Tradeup Acquisition Sponsor LLC2.63%1,145,760$941.81kInsider
Cheng Liu0.91%397,437$326.69kInsider
Jiandong Xu0.88%382,188$314.16kInsider
Hong Zhang0.55%240,481$197.68kInsider
Tao Jiang0.02%10,000$8.22kInsider
Weston Twigg0.02%10,000$8.22kInsider
James Long0.02%10,000$8.22kInsider
Armist0.01%3,975$3.27kInstitution

1 of 3

ESLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ESLA0.01%68.68%Net BuyingNet Buying
FLNA0.03%76.45%Net BuyingNet Buying
AARD0.04%46.39%Net SellingNet Selling
MGX0.02%34.76%Net BuyingNet Buying
IRLA0.00%100.00%Net Selling

Estrella Immunopharma Stock Ownership FAQ

Who owns Estrella Immunopharma?

Estrella Immunopharma (NASDAQ: ESLA) is owned by 0.01% institutional shareholders, 68.68% Estrella Immunopharma insiders, and 31.31% retail investors. Eureka Therapeutics Inc is the largest individual Estrella Immunopharma shareholder, owning 25.28M shares representing 58.11% of the company. Eureka Therapeutics Inc's Estrella Immunopharma shares are currently valued at $18.43M.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.